Company / Current Liabilities per Share
Minerva Neurosciences, Inc. Current Liabilities per Share History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.41
FY2024
5-year range
$0.07 / $0.63
FY2020-FY2024
Trend
-35.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 8 years, ranging from $0.07 in FY2021 to $0.63 in FY2023.
Based on SEC 10-K filings.
0.41 in FY2024 with a 5-year CAGR of +19.0%.
Increased from $0.26 to $0.41 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +83.2%
- 5-Year CAGR
- +19.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, current liabilities per share decreased 35.2% year-over-year.
- Peak current liabilities per share was recorded in FY2023.
- Lowest current liabilities per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.41 | -35.2% |
| FY2023 | $0.63 | +142.5% |
| FY2022 | $0.26 | +290.9% |
| FY2021 | $0.07 | -18.4% |
| FY2020 | $0.08 | -52.5% |
| FY2019 | $0.17 | +82.8% |
| FY2018 | $0.09 | -52.3% |
| FY2017 | $0.20 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026